Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 10/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.46 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8027661 | 0.81 | MME (0.63) | GAASMN1; SMN2LMNAALDH1A1TSHR | |
| SCHEMBL6570519 | 0.81 | GAA (1.00) | GAASMN1; SMN2LMNAALDH1A1PKM | |
| SCHEMBL8622747 | 0.78 | GAA (0.72) | GAASMN1; SMN2LMNAALDH1A1PKM | |
| SCHEMBL27822637 | 0.78 | GAA (0.72) | GAASMN1; SMN2LMNAALDH1A1PKM | |
| SCHEMBL10434862 | 0.75 | GAA (0.68) | GAASMN1; SMN2LMNAALDH1A1PKM | |
| SCHEMBL10117735 | 0.75 | GAA (0.68) | GAASMN1; SMN2LMNAALDH1A1PKM | |
| SCHEMBL8113450 | 0.74 | GAA (0.66) | GAASMN1; SMN2LMNAALDH1A1PKM | |
| SCHEMBL3632306 | 0.73 | GAA (0.60) | GAASMN1; SMN2LMNAALDH1A1PKM | |
| SCHEMBL9188482 | 0.73 | GAA (0.66) | GAASMN1; SMN2LMNAALDH1A1PKM | |
| SCHEMBL6634562 | 0.73 | ALOX5 (0.61) | GAASMN1; SMN2LMNAALDH1A1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8106141-B2 | Cure accelerators for anaerobic curable compositions | HENKEL CORPORATION (US) | 2012-01-31 | — | — | US | disclosed |
| US-20090277356-A1 | Cure Accelerators for Anaerobic Curable Compositions | HENKEL CORPORATION (US) | 2009-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090277356-A1 | Cure Accelerators for Anaerobic Curable Compositions | ACLY, ACAD9, CCNY | GAA 851/4885SMN1; SMN2 1004/4885LMNA 1914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.